MALAISE is the #8 most commonly reported adverse reaction for CINACALCET HYDROCHLORIDE, manufactured by Amgen Inc. There are 1,562 FDA adverse event reports linking CINACALCET HYDROCHLORIDE to MALAISE. This represents approximately 2.7% of all 57,261 adverse event reports for this drug.
Patients taking CINACALCET HYDROCHLORIDE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE1,562 of 57,261 reports
MALAISE is a less commonly reported adverse event for CINACALCET HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of CINACALCET HYDROCHLORIDE
In addition to malaise, the following adverse reactions have been reported for CINACALCET HYDROCHLORIDE:
MALAISE has been reported as an adverse event in 1,562 FDA reports for CINACALCET HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with CINACALCET HYDROCHLORIDE?
MALAISE accounts for approximately 2.7% of all adverse event reports for CINACALCET HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience MALAISE while taking CINACALCET HYDROCHLORIDE?
If you experience malaise while taking CINACALCET HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.